CDH1 and endometrial cancer: Taken together, our results constructed a circ_0007534/miR-625/ZEB2 signaling, which drives endometrial cancer progression and chemoresistance by modulating several key EMT-related genes, including Twist1, MMP2, E-cadherin, and Vimentin (Figure 10).